Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8811337rdf:typepubmed:Citationlld:pubmed
pubmed-article:8811337lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:8811337lifeskim:mentionsumls-concept:C0162326lld:lifeskim
pubmed-article:8811337lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:8811337pubmed:issue1-2lld:pubmed
pubmed-article:8811337pubmed:dateCreated1997-2-10lld:pubmed
pubmed-article:8811337pubmed:abstractTextWe examined the accessory genes and envelope V3 region of provirus obtained over a 5 year period from an HIV+ long-term non-progressor with very low viral load and no in vitro recoverable virus during that same time span. LTR sequences supported normal Tat-mediated promoter activity. Multiple clones of nef sequences were highly conserved with < 10% containing frame shift or stop codon mutations. Functional analysis of the predominant nef sequence indicated wild type downregulation of surface CD4 and good function in a complementation infectivity assay. By contrast, inactivating mutations were found in 64% of amplicons containing vif, vpr, vpu, tat1, and rev1, and in 41% of amplicons containing env V3. Identical inactive sequences were obtained at an interval of 2 years, suggesting persistence of quiescent defective provirus in a long-lived clonal cell population. Furthermore, genetic distance versus time analysis revealed an absence of progressive evolution or arborization of quasispecies over time. This contrasts with data generated from other asymptomatic HIV+ individuals. The non-progressive pattern of env sequence diversity and low R2 for genetic divergence over time suggests that the defective provirus circulating in the periphery of this patient represents a randomly sampled 'fossil record' of earlier replication competent HIV-1 genomes.lld:pubmed
pubmed-article:8811337pubmed:languageenglld:pubmed
pubmed-article:8811337pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8811337pubmed:citationSubsetIMlld:pubmed
pubmed-article:8811337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8811337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8811337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8811337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8811337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8811337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8811337pubmed:statusMEDLINElld:pubmed
pubmed-article:8811337pubmed:monthJunlld:pubmed
pubmed-article:8811337pubmed:issn0165-2478lld:pubmed
pubmed-article:8811337pubmed:authorpubmed-author:SoniJJlld:pubmed
pubmed-article:8811337pubmed:authorpubmed-author:RayS CSClld:pubmed
pubmed-article:8811337pubmed:authorpubmed-author:SchwartzD HDHlld:pubmed
pubmed-article:8811337pubmed:authorpubmed-author:MichaelNNlld:pubmed
pubmed-article:8811337pubmed:authorpubmed-author:ViscidiRRlld:pubmed
pubmed-article:8811337pubmed:authorpubmed-author:LaeyendeckerO...lld:pubmed
pubmed-article:8811337pubmed:issnTypePrintlld:pubmed
pubmed-article:8811337pubmed:volume51lld:pubmed
pubmed-article:8811337pubmed:ownerNLMlld:pubmed
pubmed-article:8811337pubmed:authorsCompleteYlld:pubmed
pubmed-article:8811337pubmed:pagination3-6lld:pubmed
pubmed-article:8811337pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:meshHeadingpubmed-meshheading:8811337-...lld:pubmed
pubmed-article:8811337pubmed:year1996lld:pubmed
pubmed-article:8811337pubmed:articleTitlePredominance of defective proviral sequences in an HIV + long-term non-progressor.lld:pubmed
pubmed-article:8811337pubmed:affiliationDepartment of Molecular Microbiology and Immunology, Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205, USA.lld:pubmed
pubmed-article:8811337pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8811337lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8811337lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8811337lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8811337lld:pubmed